Vericel (VCEL) director gains RSUs, options and more common shares
Rhea-AI Filing Summary
Vericel Corp director Alan L. Rubino increased his equity-based holdings through routine compensation awards and vesting. He acquired 3,200 shares of common stock via the vesting and conversion of previously granted Restricted Stock Units (RSUs), bringing his direct common stock holdings to 64,194 shares.
He also received a new grant of 3,200 RSUs, each representing a contingent right to one Vericel common share, which vest 100% on the earlier of April 29, 2027, or the first Annual Meeting of Stockholders following April 29, 2026. In addition, he was granted stock options for 8,000 shares at an exercise price of $33.43 per share, vesting in equal monthly increments over one year and expiring on April 29, 2036. These transactions reflect equity compensation and do not include any open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 3,200 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 8,000 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 3,200 | $0.00 | -- |
| Exercise | Common Stock | 3,200 | $0.00 | -- |
Footnotes (1)
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 30, 2025. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025. No expiration date for this type of award. The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.